검색어 : 통합검색[Dayton Jonathan]
총 324건 중 324건 출력
, 33/33 페이지
-
321
- Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
- Isa, Flonza; Forleo-Neto, Eduardo; Meyer, Jonathan; Zheng, Wenjun; Rasmussen, Scott; Armas, Danielle; Oshita, Masaru; Brinson, Cynthia; Folkerth, Steven; Faria, Lori; Heirman, Ingeborg; Sarkar, Neena; Musser, Bret J.; Bansal, Shikha; O'Brien, Meagan P.; Turner, Kenneth C.; Ganguly, Samit; Mahmood, Adnan; Dupljak, Ajla; Hooper, Andrea T.; Hamilton, Jennifer D.; Kim, Yunji; Kowal, Bari; Soo, Yuhwen; Geba, Gregory P.; Lipsich, Leah; Braunstein, Ned; Yancopoulos, George D.; Weinreich, David M.; Herman, Gary A.; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Celerion, Lincoln, NE, USA; Celerion, Tempe, AZ, USA; Benchmark Research, Sacramento, CA, USA; Central Texas Clinical Research, LLC, Austin, TX, USA; Midwest Clinical Research Center, LLC, Dayton, OH, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc.,; (International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, v.122, 2022, pp.585-592)
-
322
- ECOG-ACRIN E1411 randomized phase 2 trial of bendamustine-rituximab (BR)-based induction followed by rituximab (R) ± lenalidomide (L) consolidation for Mantle cell lymphoma: Effect of adding bortezomib to front-line BR induction on PFS.
- Smith, Mitchell Reed; Jegede, Opeyemi; Martin, Peter; Till, Brian G.; Parekh, Samir S.; Yang, David T; Kostakoglu, Lale; Casulo, Carla; Bartlett, Nancy L.; Caimi, Paolo Fabrizio; Al Baghdadi, Tareq; Maddocks, Kami J.; Romer, Mark D.; Inwards, David James; Lerner, Rachel E.; Wagner, Lynne I.; Little, Richard F.; Friedberg, Jonathan W.; Leonard, John Paul; Kahl, Brad S.; GW University, Washington, DC; ; Dana Farber Cancer Institute, Boston, MA; ; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY; ; Fred Hutchinson Cancer Rsrch Ctr, Seattle, WA; ; Mount Sinai, New York, NY; ; University of Wisconsin Carbone Cancer Center, Madison, WI; ; University of Virginia, Charlottesville, TN; ; University of Rochester Medical Center-James P. Wilmot Cancer Center, Rochester, NY; ; Washington University School of Medicine in St. Louis and Siteman Cancer Center, St. Louis, MO; ; Adult Hematologic Malignancies and Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH; ; IHA Hematology Oncology Consultants, Ypsilanti, MI; ; Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH; ; Good Samaritan Hospital-Dayton, Kettering, OH; ; Division of Hematology, Mayo Clinic, Rochester, MN; ; Frauenshuh Cancer Center and Park Nicollet Institute, Minn; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.7503-7503)
-
323
- Book Reviews
- Spall, Richard F.; Austen, Ralph A.; Austen, Ralph A.; Louis, Wm. Roger; Mcclellan, Charles W.; Aksan, Virginia H.; Mahdi, Ali Akbar; Simpson, Brooks D.; Braeman, John; Ferrer, Ada; Varon, Elizabeth R.; Smith, Michael O.; Walker, William O.; Gaskins, Susanne Teepe; Morgan, David T.; Jennings, Francis; O'donnell, Mabry M.; Keyes, Jonathan J.; Couvares, Francis G.; Hattaway, Herman; Winter, Thomas; Harmond, Richard; Boyd, Steven R.; Winter, Thomas; Cahall, Michael C.; Wilson, Raymond; Fletcher, Marvin E.; Bakken, Gordon Morris; Alexander, Roberta Sue; Thomas, Julia Adeney; Yu, Bin; Park, Nancy; Adolphson, Mikael S.; Entenmann, Robert; Sinha, Mrinalini; Rosenbaum, Arthur Lewis; Rossabi, Morris; Munson, Rosaria Vignolo; Kollander, Patricia; Bahm, Karl F.; Wolber, Thomas K.; Carroll, Francis M.; Gilbert, Bentley Brinkerhoff; Russell, Conrad; Deshmukh, Marion F.; Major, J. Russell; Cox, Jeffrey; Gullace, Nicoletta F.; Dreher, Nan H.; Bacon, Ew; Ohio Wesleyan University; University of Chicago; University of Chicago; University of Texas at Austin; Radford University; McMaster University; Ohio Wesleyan University; Arizona State University; University of Nebraska‐ Lincoln; New York University; Wellesley College; Walter Reuther Library; Ohio Wesleyan University; Fort Lewis College; University of Montevallo; Newberry Library, Emeritus; Marietta College; University of Chicago; Amherst College; University of Missouri‐ Kansas City; University of Cincinnati; St. John's University; University of Texas; University of Cincinnati; Duquesne University; Fort Hays State University; Ohio University; California State University, Fullerton; University of Dayton; University of Wisconsin‐ Madison; Wittenberg University; Vassar College; University of Oklahoma; St. Olaf College; Boston College; Claremont McKenna College; City University of New York; Swarthmore College; Florida Atlantic Universi; (The Historian: a journal of history, v.59, 1997, pp.859-947)
-
324
- 729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis
- Gooderham, Melinda; Lynde, Charles; Alam, Maryam Shayesteh; Sadick, Neil; Rohan, Craig A; Werschler, William Philip; Hebert, Adelaide A; Laquer, Vivian T; Sauder, Maxwell; Del Rosso, James Q; Rodgers, Timothy; Tan, Ricardo; Schleicher, Stephen; Murrell, Dedé e F; Fernandez-Peñ as, Pablo; Reich, Adam; Gkalpakiotis, Spyridon; Ruiz, Juan Ruano; Wollenberg, Andreas; Szepietowski, Jacek C; Sticherling, Michael; Weyergraf, Ansgar J; Ljubojević Hadž avdić , Suzana; Baran, Wojciech; Vilchez, Trinidad Montero; Eniko, Telegdy; Sebastian, Michael; Chaudhry, Sohail; Lee, Zachary; Yu, Danni; Liu, Yi; Waltz, Wang; Gilbert, Jenny; Elko-Simms, Lucinda M; Fanton, Christie; Jue, Charleen; Tagliaferri, Mary; Zalevsky, Jonathan; Rosmarin, David; Department of Medicine, Queen’s University , Kingston, ON , Canada; Division of Dermatology, Department of Medicine, University of Toronto , Toronto, ON , Canada; SimcoMed Health Ltd , Barrie, ON , Canada; Department Of Dermatology, Weill Cornell Medicine , New York, NY , USA; Dermatology, Boonshoft School of Medicine at Wright State University , Dayton, OH , USA; Department of Medicine/Dermatology, University of Washington , Seattle, WA , USA; University of Texas Health Science Center Houston , Houston, TX , USA; First OC Dermatology Research , Fountain Valley, CA , USA; Division of Dermatology, Department of Medicine, University of Toronto , Toronto, ON , Canada; Lakes Dermatology and Del Rosso Dermatology Research Center , Las Vegas, NV , USA; North Texas Center for Clinical Research , Frisco, TX , USA; California Allergy & Asthma , Los Angeles, CA , USA; DermDox Centers for Dermatology , Sugarloaf, PA , USA; School of Medicine, University of Notre Dame , Sydney, NSW; (British journal of dermatology : BJD, v.191, 2024, pp.ljae266.102)
QUICK MENU
